| Year |
Citation |
Score |
| 2016 |
Griebel G, Pichat P, Boulay D, Naimoli V, Potestio L, Featherstone R, Sahni S, Defex H, Desvignes C, Slowinski F, Vigé X, Bergis OE, Sher R, Kosley R, Kongsamut S, et al. The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia. Scientific Reports. 6: 35320. PMID 27734956 DOI: 10.1038/Srep35320 |
0.437 |
|
| 2015 |
Naimoli V, Featherstone R, Potestio L, Kosley R, Varty G, Griebel G, Black M. Compound A, a novel, potent and selective mGluR2 positive allosteric modulator: III. Effects in clinically relevant translational cognition models that could be used as biomarkers F1000research. 4. DOI: 10.7490/F1000Research.1110033.1 |
0.543 |
|
| 2011 |
Rogacki N, Lopez-Grancha M, Naimoli V, Potestio L, Stevens RJ, Pichat P, Bergis OE, Cohen C, Varty GB, Griebel G. The neurokinin NK2 antagonist, saredutant, ameliorates stress-induced conditions without impairing cognition. Pharmacology, Biochemistry, and Behavior. 98: 405-11. PMID 21115031 DOI: 10.1016/J.Pbb.2010.11.017 |
0.538 |
|
| 2010 |
Overstreet DH, Naimoli VM, Griebel G. Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression. Pharmacology, Biochemistry, and Behavior. 96: 206-10. PMID 20470817 DOI: 10.1016/J.Pbb.2010.05.006 |
0.359 |
|
| Show low-probability matches. |